Literature DB >> 11862220

Structural basis of BLyS receptor recognition.

Deena A Oren1, Yuling Li, Yulia Volovik, Tina S Morris, Chhaya Dharia, Kalyan Das, Olga Galperina, Reiner Gentz, Eddy Arnold.   

Abstract

B lymphocyte stimulator (BLyS), a member of the tumor necrosis factor (TNF) superfamily, is a cytokine that induces B-cell proliferation and immunoglobulin secretion. We have determined the three-dimensional structure of BLyS to 2.0 A resolution and identified receptor recognition segments using limited proteolysis coupled with mass spectrometry. Similar to other structurally determined TNF-like ligands, the BLyS monomer is a beta-sandwich and oligomerizes to form a homotrimer. The receptor-binding region in BLyS is a deeper, more pronounced groove than in other cytokines. The conserved elements on the 'floor' of this groove allow for cytokine recognition of several structurally related receptors, whereas variations on the 'walls' and outer rims of the groove confer receptor specificity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11862220     DOI: 10.1038/nsb769

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  13 in total

1.  LC-mass spectrometry analysis of N- and C-terminal boundary sequences of polypeptide fragments by limited proteolysis.

Authors:  Justin G Stroh; Pat Loulakis; Anthony J Lanzetti; Julie Xie
Journal:  J Am Soc Mass Spectrom       Date:  2005-01       Impact factor: 3.109

2.  Structural insights into the C1q domain of Caprin-2 in canonical Wnt signaling.

Authors:  Haofei Miao; Yingying Jia; Sichun Xie; Xin Wang; Jianfei Zhao; Youjun Chu; Zhilei Zhou; Zhubing Shi; Xiaomin Song; Lin Li
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

3.  Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma.

Authors:  Xiaoxia Wen; Mi-Ae Lyu; Rui Zhang; Wei Lu; Qian Huang; Dong Liang; Michael G Rosenblum; Chun Li
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

4.  Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Authors:  Sonia Schuepbach-Mallepell; Dolon Das; Laure Willen; Michele Vigolo; Aubry Tardivel; Luc Lebon; Christine Kowalczyk-Quintas; Josquin Nys; Cristian Smulski; Timothy S Zheng; Klaus Maskos; Alfred Lammens; Xuliang Jiang; Henry Hess; Seng-Lai Tan; Pascal Schneider
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

5.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

6.  Ancient BCMA-like Genes Herald B Cell Regulation in Lampreys.

Authors:  Sabyasachi Das; Yoichi Sutoh; Michael P Cancro; Jonathan P Rast; Qifeng Han; Gayathri Bommakanti; Max D Cooper; Masayuki Hirano
Journal:  J Immunol       Date:  2019-10-30       Impact factor: 5.422

7.  Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo.

Authors:  Troy A Luster; Ipsita Mukherjee; Jeffrey A Carrell; Yun Hee Cho; Jeffrey Gill; Lizbeth Kelly; Andy Garcia; Christopher Ward; Luke Oh; Stephen J Ullrich; Thi-Sau Migone; Robin Humphreys
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

8.  B-cell-activating factor and autoimmune myasthenia gravis.

Authors:  Samia Ragheb; Robert P Lisak
Journal:  Autoimmune Dis       Date:  2011-11-28

9.  Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.

Authors:  Madelyn R Schmidt; Michael C Appel; Lisa J Giassi; Dale L Greiner; Leonard D Shultz; Robert T Woodland
Journal:  PLoS One       Date:  2008-09-11       Impact factor: 3.240

10.  BCMA is essential for the survival of long-lived bone marrow plasma cells.

Authors:  Brian P O'Connor; Vanitha S Raman; Loren D Erickson; W James Cook; Lehn K Weaver; Cory Ahonen; Ling-Li Lin; George T Mantchev; Richard J Bram; Randolph J Noelle
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.